MedTrace Logo

Genomic Approaches to Common Chronic Disease - Ancillary to ARIC

NCT00808353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15792

Last updated 2008-12-15

No results posted yet for this study

Summary

The ARIC study is a prospective epidemiologic study conducted in four U.S. communities and designed to investigate the etiology and natural history of atherosclerosis, the etiology of clinical atherosclerotic diseases, and variation in cardiovascular risk factors, medical care and disease by race, gender, location, and date.

Conditions

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • Cornell University

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • University of Michigan

    lead OTHER

Principal Investigators

  • Eric Boerwinkle, PhD · Univeristy of Texas Houston Health Science Center School of Public Health

Eligibility

Min Age
45 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1985-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00808353 on ClinicalTrials.gov